Gsk (GLAXF) Exchange Rate Effect (2009 - 2026)

Gsk's Exchange Rate Effect history runs 18 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• In Q1 2026, Exchange Rate Effect rose 119.46% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at -$100.3 million (up 44.81% YoY), while the FY2025 annual figure was -$25.1 million, up 63.71% from the prior year.
• Exchange Rate Effect was $2.7 million for Q1 2026 at Gsk, up from -$54.5 million in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $97.4 million in Q4 2022 to a low of -$109.2 million in Q4 2023.
• Historically, Exchange Rate Effect has averaged -$17.5 million across 5 years, with a median of -$24.1 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Exchange Rate Effect soared 312.41% in 2022, then slumped 334.01% in 2023.
• A 5-year view of Exchange Rate Effect shows it stood at $97.4 million in 2022, then slumped by 212.19% to -$109.2 million in 2023, then surged by 68.27% to -$34.7 million in 2024, then tumbled by 57.37% to -$54.5 million in 2025, then soared by 104.94% to $2.7 million in 2026.
• The last three Exchange Rate Effect figures came in at $2.7 million (Q1 2026), -$54.5 million (Q4 2025), and -$13.9 million (Q1 2025), per Business Quant data.